The Oncosearch | Oncotarget

Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays Research Paper

Mustafa A. Barbhuiya, Manoj K. Kashyap, Vinuth N. Puttamallesh, Rekha Vijay Kumar, Xinyan Wu, Akhilesh Pandey, Harsha Gowda

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18422-18434

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

Ewelina Dratkiewicz, Katarzyna Pietraszek-Gremplewicz, Aleksandra Simiczyjew, Antonina Joanna Mazur, Dorota Nowak

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18254-18268

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Sena, Hong Wu, Aiping Dong, Hong Zeng, Fengling Li, Renato Ferreira de Freitas, Mohammad S. Eram, Matthieu Schapira, Yuji Baba, Mihoko Kunitomo, Douglas R. Cary, Michiko Tawada, Akihiro Ohashi, Yasuhiro Imaeda, Kumar Singh Saikatendu, Charles E. Grimshaw, Masoud Vedadi, Cheryl H. Arrowsmith, Dalia Barsyte-Lovejoy, Atsushi Kiba, Daisuke Tomita, Peter J. Brown

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18480-18493

Expression of HNF4G and its potential functions in lung cancer Research Paper

Jingyu Wang, Jun Zhang, Longsheng Xu, Ying Zheng, Danyan Ling, Zhiping Yang

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18018-18028

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies Research Paper

Norbert Vey, Lionel Karlin, Sophie Sadot-Lebouvier, Florence Broussais, Dominique Berton-Rigaud, JÃ©rÃ´me Rey, Aude Charbonnier, Delphine Marie, Pascale AndrÃ©, Carine Paturel, Robert Zerbib, Jaafar Bennouna, Gilles Salles, Anthony GonÃ§alves

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17675-17688

Similar expression profiles in CD34⁺ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib Research Paper

Ami B. Patel, Thoralf Lange, Anthony D. Pomicter, Christopher J. Conley, Christina A. Harrington, Kimberly R. Reynolds, Todd W. Kelley, Thomas Oâ€™Hare, Michael W. Deininger

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17889-17894

The role of oxidative stress in activity of anticancer thiosemicarbazones Research Paper

Katarzyna Malarz, Anna Mrozek-Wilczkiewicz, Maciej Serda, Marta Rejmund, Jaroslaw Polanski, Robert Musiol

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17689-17710

Aloe-emodin as drug candidate for cancer therapy Research Paper

Nadire Ã–zenver, Mohamed Saeed, LÃ¼tfiye Ã–mÃ¼r Demirezer, Thomas Efferth

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17770-17796

Use of iodine concentration in lipid-poor portion of renal mass in differentiation of angiomyolipoma from renal cell carcinoma Research Paper

Jia Sun, Xiao-Yan Zhang, Xiao-Ting Li, Yan-Ling Li, Zhi-Long Wang

Published Apr 2, 2018

Prognostic value of circulating microRNAs in upper tract urinary carcinoma Research Paper

Ruth Montalbo, Laura Izquierdo, Mercedes Ingelmo-Torres, Juan JosÃ© Lozano, David CapitÃ¡n, Antonio Alcaraz, Lourdes Mengual

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16691-16700

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Stefania Acciardo, Lionel Mignion, Nicolas Joudiou, Caroline Bouzin, Jean-FranÃ§ois Baurain, Bernard Gallez, BÃ©nÃ©dicte F. Jordan

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16832-16846

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Yoshiaki Yamamoto, Ryouichi Tsunedomi, Yusuke Fujita, Toru Otori, Mitsuyoshi Ohba, Yoshihisa Kawai, Hiroshi Hirata, Hiroaki Matsumoto, Jun Haginaka, Shigeo Suzuki, Rajvir Dahiya, Yoshihiko Hamamoto, Kenji Matsuyama, Shoichi Hazama, Hiroaki Nagano, Hideyasu Matsuyama

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17160-17170

Results and adverse events of personalized peptide receptor radionuclide therapy with ⁹⁰Yttrium and ¹⁷⁷Lutetium in 1048 patients with neuroendocrine neoplasms Research Paper

Richard P. Baum, Harshad R. Kulkarni, Aviral Singh, Daniel Kaemmerer, Dirk Mueller, Vikas Prasad, Merten Hommann, Franz C. Robiller, Karin Niepsch, Holger Franz, Arthur Jochems, Philippe Lambin, Dieter HÃ¶rsch

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16932-16950

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas Research Paper

Chia-Kuang Tsai, Li-Chun Huang, Wen-Chiuan Tsai, Shih-Ming Huang, Jiunn-Tay Lee, Dueng-Yuan Hueng

Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15705-15720

Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer Research Paper

Ariadna Tibau, GeÃ²rgia Anguera, Fernando AndrÃ©s-Petrel, Arnoud J. Templeton, Bostjan Seruga, AgustÃ Barnadas, Eitan Amir, Alberto Ocana

Published Mar 13, 2018 · Vol. 9, No. 19 · pp. 15061-15067

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients Research Paper

Mario Tiribelli, Massimiliano Bonifacio, Gianni Binotto, Alessandra Iurlo, Francesca Cibien, Elena Maino, Anna Guella, Gianluca Festini, Claudia Minotto, Ercole De Biasi, Federico De Marchi, Luigi Scaffidi, Luca Frison, Cristina Bucelli, Marta Medeot, Elisabetta Calistri, Rosaria Sancetta, Manuela Stulle, Nicola Orofino, Mauro Krampera, Filippo Gherlinzoni, Gianpietro Semenzato, Giovanni Pizzolo, Achille Ambrosetti, Renato Fanin

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14219-14227

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

Daniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, Lixia Diao, Jing Wang, Lerong Li, Pan Tong, Mia Hofstad, Babita Saigal, Ignacio Wistuba, Neda Kalhor, Stephen Swisher, Youhong Fan, Waun Ki Hong, Milind Suraokar, Carmen Behrens, Cesar Moran, John Victor Heymach

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14268-14284

Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements Research Paper

Viktoria N. Evdokimova, Manoj Gandhi, Alyaksandr V. Nikitski, Christopher J. Bakkenist, Yuri E. Nikiforov

Published Feb 7, 2018 · Vol. 9, No. 17 · pp. 13612-13622

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells Research Paper

Akito Nakamura, Daisuke Nakata, Yuichi Kakoi, Mihoko Kunitomo, Saomi Murai, Shunsuke Ebara, Akito Hata, Takahito Hara

Published Feb 6, 2018 · Vol. 9, No. 17 · pp. 13474-13487

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells Research Paper

Andoni Garitano-Trojaola, Edurne San JosÃ©-EnÃ©riz, Teresa Ezponda, Juan Pablo Unfried, Arantxa Carrasco-LeÃ³n, Nerea Razquin, Marina Barriocanal, Amaia Vilas-Zornoza, Bruno Sangro, Victor Segura, Felipe PrÃ³sper, Puri Fortes, Xabier Agirre

Published Feb 5, 2018 · Vol. 9, No. 16 · pp. 12842-12852

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays Research Paper

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Expression of HNF4G and its potential functions in lung cancer Research Paper

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies Research Paper

Similar expression profiles in CD34⁺ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib Research Paper

The role of oxidative stress in activity of anticancer thiosemicarbazones Research Paper

Aloe-emodin as drug candidate for cancer therapy Research Paper

Use of iodine concentration in lipid-poor portion of renal mass in differentiation of angiomyolipoma from renal cell carcinoma Research Paper

Prognostic value of circulating microRNAs in upper tract urinary carcinoma Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Results and adverse events of personalized peptide receptor radionuclide therapy with ⁹⁰Yttrium and ¹⁷⁷Lutetium in 1048 patients with neuroendocrine neoplasms Research Paper

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas Research Paper

Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer Research Paper

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients Research Paper

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements Research Paper

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells Research Paper

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays Research Paper

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines Research Paper

TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Research Paper

Expression of HNF4G and its potential functions in lung cancer Research Paper

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies Research Paper

Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib Research Paper

The role of oxidative stress in activity of anticancer thiosemicarbazones Research Paper

Aloe-emodin as drug candidate for cancer therapy Research Paper

Use of iodine concentration in lipid-poor portion of renal mass in differentiation of angiomyolipoma from renal cell carcinoma Research Paper

Prognostic value of circulating microRNAs in upper tract urinary carcinoma Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma Clinical Research Papers

Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms Research Paper

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas Research Paper

Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer Research Paper

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients Research Paper

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements Research Paper

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells Research Paper

Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells Research Paper

Similar expression profiles in CD34⁺ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib Research Paper

Results and adverse events of personalized peptide receptor radionuclide therapy with ⁹⁰Yttrium and ¹⁷⁷Lutetium in 1048 patients with neuroendocrine neoplasms Research Paper